🔗 Share this article

The top legal official in Texas Paxton is suing the producers of acetaminophen, asserting the corporations hid potential risks that the pain reliever presented to children's cognitive development.

The lawsuit follows thirty days after President Donald Trump promoted an unverified association between using acetaminophen - alternatively called paracetamol - while pregnant and autism in offspring.

The attorney general is filing suit against J&J, which formerly manufactured the medication, the sole analgesic approved for expectant mothers, and the current manufacturer, which now manufacturers it.

In a statement, he stated they "deceived the public by profiting off of discomfort and promoting medication without regard for the dangers."

The manufacturer says there is lacking scientific proof linking Tylenol to autism spectrum disorder.

"These corporations lied for decades, knowingly endangering numerous people to increase profits," Paxton, a Republican, declared.

The manufacturer stated officially that it was "seriously troubled by the dissemination of inaccurate information on the security of paracetamol and the possible consequences that could have on the welfare of women and children in America."

On its website, Kenvue also stated it had "regularly reviewed the relevant science and there is no credible data that indicates a established connection between using acetaminophen and autism spectrum disorder."

Organizations acting on behalf of physicians and medical practitioners agree.

ACOG has declared acetaminophen - the primary component in acetaminophen - is among limited choices for pregnant women to manage discomfort and elevated temperature, which can create serious health risks if left untreated.

"In more than two decades of studies on the use of acetaminophen in pregnancy, not a single reputable study has definitively established that the use of acetaminophen in any trimester of pregnancy causes brain development issues in offspring," the group commented.

The lawsuit references current declarations from the former administration in arguing the medication is potentially dangerous.

Recently, Trump generated worry from medical authorities when he advised women during pregnancy to "fight like hell" not to take Tylenol when sick.

Federal regulators then released a statement that doctors should think about restricting the use of acetaminophen, while also declaring that "a direct connection" between the drug and autism spectrum disorder in minors has not been proven.

The Health Department head RFK Jr, who manages the FDA, had vowed in spring to conduct "extensive scientific investigation" that would identify the origin of autism spectrum disorder in a short period.

But specialists warned that finding a unique factor of autism - considered by experts to be the outcome of a complicated interplay of inherited and environmental factors - would prove challenging.

Autism is a type of lifelong neurodivergence and condition that affects how persons perceive and engage with the environment, and is identified using medical professional evaluations.

In his lawsuit, the attorney general - a Trump ally who is campaigning for federal office - alleges Kenvue and J&J "deliberately disregarded and sought to suppress the research" around paracetamol and autism spectrum disorder.

This legal action attempts to require the corporations "destroy any promotional materials" that states acetaminophen is reliable for pregnant women.

The Texas lawsuit echoes the concerns of a assembly of parents of children with autism spectrum disorder and attention deficit hyperactivity disorder who sued the producers of Tylenol in two years ago.

The court dismissed the lawsuit, declaring research from the family's specialists was lacking definitive proof.